Leaps by Bayer
Corporate VCLeverkusen · Seed–Growth · 7 people tracked
Find your way into Leaps by Bayer
1,469 people in our graph share verified history with the Leaps by Bayer team — schools, employers, funds. One of them is your warm intro.
Team · 7 people
from curated & public directories
What they invest in
from 43 of 46 portfolio companiesBiotech ×29Healthtech ×18AI & Machine Learning ×12Deep Tech ×12Digital Health ×11AgTech ×7Medical Devices ×5Climate Tech ×3
HQs:United States×31Australia×1Singapore×1
Investments · 46 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 62023 · 52022 · 72021 · 62020 · 22019 · 32018 · 12017 · 134 dated
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Co-investorsBios PartnersConnecticut InnovationsKdT Ventures
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Richard Young, Ph.D.(Director)Anthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inAmeet Nathwani, M.D.(Executive Officer, Director)in
Co-investorsARCH Venture PartnersEcoR1 CapitalSamsara BioCapital6 Dimensions CapitalGeneral CatalystInnovation Endeavors+5 more
.png)
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsREDMILEDigitalis VenturesDreamers VCRising TideAccess IndustriesAtlas Venture+2 more
Indapta Therapeutics develops an off-the-shelf, allogeneic FcRγ-deficient natural killer (g-NK) cell therapy derived from healthy donors to treat cancer and autoimmune diseases.
BiotechHealthtechHouston, US
Guy DiPierro(Chief Operating Officer & Co-Founder)inSungjin Kim(Scientific Founder)John Sunwoo(Scientific Founder)Mark W. Frohlich(Chief Executive Officer)Stefanie Mandl-Cashman(Acting Chief Scientific Officer)
Co-investorsRA CapitalVertex Ventures HC
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo CapitalARCH Venture Partners+1 more
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.
AI & Machine LearningBiotechDeep TechWatertown, US
Victor Kotelianski(Founder)Daniel Anderson(Founder and Director)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat, ScD(Founder, Director and CEO)
Co-investorsBessemer Venture PartnersSafar PartnersVida VenturesPolaris Partners
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesClavystBio
Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions.
AI & Machine LearningDigital HealthHealthtech
Co-investorsRed River WestSamsung Catalyst FundUrania Ventures10x FoundersBertelsmann InvestmentsMutschler Ventures+1 more
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalOlive Tree CapitalService Provider CapitalFred Hutchinson Cancer Research CenterHumboldtVida Ventures
BiotechWatertown, US
Kathy Bergsteinsson(Executive Officer)inKathy Yi(Executive Officer)inJoseph Knowles(Executive Officer, Director)
BoardLucio Iannone(Director)inArjun Goyal(Director)Jill DeSimone(Director)
Co-investorsVida Ventures
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager Partners+3 more
Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.
AgTechCleantechClimate TechImpact & Social GoodAlameda, US
Co-investorsCavallo VenturesKdT VenturesVoyager Partners
Apollo Agriculture provides small-scale farmers with farming inputs, financing, insurance, and training to help them run more profitable agribusinesses.
AgTechAI & Machine LearningFintechImpact & Social GoodOakland, US
Earl Joseph St. Sauver(Director)inEli Pollak(CEO)inBenjamin Njenga(CCO & Co-Founder)inEarl St Sauver(Co-Founder)in
BoardSeth Todd Silverman(Director)in
Co-investorsAccionAnthemis VentureCeniarthCommunitas Capital PartnersEndeavor CatalystEquator+6 more
BiotechDavis, US
Steven Watkins(Executive Officer, Director, Promoter)Carlito Lebrilla(Director, Promoter)
Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundMitsui & CoMorado Ventures+1 more
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsJoyance PartnersPsyMed VenturesSocial StartsApollo Health Ventures
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCCavallo VenturesKdT Ventures
Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.
BiotechHealthtechMedical Devices
Co-investorsPureTech HealthRA Capital
BiotechGermantown, US
John Mumm(Executive Officer, Director)Vera Mumm(Executive Officer)Pavel Khrimian(Executive Officer, Director)Lucio Iannone(Director)Sally (Yuanheng) Wang(Director)
Co-investorsLumira VenturesPlains VenturesEcho Investment CapitalMPM BioImpact
Dewpoint Innovations develops functional nanostructured polymeric surfaces for atmospheric water capture, technology originating from PhD research at the University of Sydney.
CleantechClimate TechDeep TechNew Materials
Chiara Neto(Founder & Advisor (Chief Scientific Officer))inMing Chiu(Founder & CTO)in
Co-investorsPacific Channel3E Bioventures CapitalARCH Venture PartnersEcoR1 CapitalGeneral CatalystMaverick Ventures+2 more
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)in
Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsAhren Innovation CapitalVertical Venture Partners
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla VenturesOUP (Osage University Partners)b2venture+1 more
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.
BiotechDeep TechFoodTechNutley, US
Gabor Forgacs(Chief Scientific Officer and co-founder)inAndras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)in
BoardLauren Loktev(Director)
Co-investorsAIR CapitalBBG VenturesCollaborative FundMindshift CapitalThe Venture CollectiveStarlight Ventures+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesAmgen Ventures
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.+3 more
Khloris Biosciences develops iPSC-based cancer vaccines, using induced pluripotent stem cells to trigger a multi-faceted anti-tumor immune response.
BiotechHealthtechLongevitySouth San Francisco, US
Joseph C. Wu(Director)Lynne A. Bui(Co-Founder, President, CEO, and Chairman of the Board)
Leaf Trade is a B2B marketplace platform connecting cannabis cultivators and dispensaries for wholesale transactions.
AgTechB2B MarketplacesFintechSaaS
Co-investorsArtemis Growth PartnersChingona VenturesHyde Park Angels
MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.
HealthtechLogistics & Supply ChainSaaSNew York, US
Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)
BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in
Co-investors7wire VenturesCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine Ventures+2 more
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+4 more
Nava Benefits is a technology-enabled benefits brokerage that pairs benefits consultants with AI-powered tools to help HR teams manage employee health benefits with less administrative work and lower costs.
HealthtechHR TechInsurTech
Brandon Weber(Founder)in
Co-investorsArchetypeAvid VenturesGlynn Capital ManagementHomebrewRA Capital
NewLeaf develops PPFM (Pink-Pigmented Facultative Methylotroph) microbial technologies for agriculture, offering EPA-registered biofungicide and bioinsecticide products (TS601 and TS201) plus crop-specific biostimulants for growers of corn, soy, cotton, rice and other crops.
AgTechBiotechSt. Louis, US
Thomas Laurita(Executive Officer, Director)Michael McFatrich(Executive Officer)Desmond Jimenez(Executive Officer)inStephen Kahn(Executive Officer)Janne Kerovuo(Executive Officer)inDoug Bryant(Executive Officer)
Co-investorsPangaea Ventures Us Inc.S2G InvestmentsSABIC VenturesPangaea Ventures
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)in
Co-investorsAcre Venture PartnersAlpha EdisonBetter Ventures Central LlcCollaborative FundDoon CapitalE12 Venture Capital, Llc+4 more
.png)
Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.
AI & Machine LearningBiotechDeep TechUnited States, US
Co-investorsARCH Venture PartnersClavystBioEcoR1 Capital
Iowa City, US
Matthew Beckwith(Executive Officer, Director)Michael Ott(Executive Officer, Director)
Co-investorsFulcrum Global CapitalInnova Memphis, Inc.
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound enhancing agents) to deliver genetic payloads to targeted sites in a redosable manner.
BiotechDeep TechDigital Health
Kenneth Greenberg(Founder)in
Co-investorsARCH Venture PartnersSymBiosisUCB VenturesVida VenturesVivo Capital
AgTechEmeryville, US
Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)in
Co-investorsCavallo VenturesCultivian Sandbox VenturesS2G InvestmentsFall Line CapitalFootPrint CoalitionNorthpond Ventures+2 more
Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.
ConsumerDigital HealthHealthtech
Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+6 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesAlly Bridge GroupGeneral CatalystGeodesic CapitalHuman Capital+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Chief Executive Officer)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.
BiotechHealthtechMedical DevicesAustin, US
TERESA MCROBERTS(Executive Officer)inPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJON IRVIN(Executive Officer)in
BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)
Co-investorsB Capital GroupB4 CapitalCheckmate Capital Group LLCNorthpond VenturesOceanpine Capital
.jpeg){kind=logo}
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)inYanay Ofran(Director)inJudith Weiss Paltiel(PhD, VP Development)in
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsIsrael Biotech FundKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalPeakBridge VC
Digital health company advancing digestive care.
HealthtechHouston, US
Sally Welborn(Director)William Snyder(Executive Officer, Director)Marco Veremis(Director)inShawn Ellis(Director)inSanford Duncan(Director)Andrew Bouldin(Director)in
Co-investors7wire VenturesBig Pi VenturesFCA Venture PartnersHealth Catalyst CapitalHuman CapitalLifeforce Capital+1 more
Woebot Health builds chat-based AI wellness tools to provide mental health support to individuals and organizations.
AI & Machine LearningDigital HealthMental Health
Alison Darcy(Founder)in
Co-investorsJAZZ Venture PartnersOwl VenturesAI FundNew Enterprise Associates (NEA)Temasek
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BE BiopharmaCaspian Therapeutics
Exits · 1
1 IPOsAzitraNYSE: AZTR
Portfolio news
latest coverage across their companiesWoebot · chiefhealthcareexecutive.com · Aug 15, 2026
SonoThera · fiercebiotech.com · Aug 12, 2026
Metagenomi · za.investing.com · Aug 11, 2026
Celea Therapeutics · kalkine.co.uk · Aug 10, 2026
Summer Health · mobihealthnews.com · Jul 29, 2026
NewLeaf Symbiotics · agropages.com · Jul 24, 2026
SonoThera · statnews.com · Jul 17, 2026
Frequently asked questions
- How many investments has Leaps by Bayer made?
- Leaps by Bayer has 46 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does Leaps by Bayer invest at?
- Leaps by Bayer invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Leaps by Bayer focus on?
- Leaps by Bayer focuses on AgTech, Biotech, Healthtech.
- Where is Leaps by Bayer located?
- Leaps by Bayer is headquartered in Leverkusen, DE.
Co-investors · 16
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs across all stages of development.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
Paladin Capital Group invests in early stage and growth companies developing cyber, AI and deep technologies that address security and resilience needs for commercial and government customers.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
The Column Group (TCG) is a venture capital firm focused on building and backing biotechnology companies, applying an edge-to-edge investment model centered on company formation with capacity for long-term private and public capital support.
Innova Memphis is a seed-stage investment firm that funds and mentors early-stage, high-growth companies, currently focused on AgTech and FarmTech ventures with strong intellectual property or competitive advantages.
Fulcrum Global Capital is the venture capital arm of a US agriculture producer that invests in companies addressing global food system challenges driven by population growth and demographic shifts.
▶4 more co-investors
Firms observed investing alongside Leaps by Bayer, from public investor directories. Shared companies are the overlap with Leaps by Bayer's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Rho is an investment firm founded in 1981 that backs inventors, entrepreneurs, and operators across all stages of company growth to build market-defining companies.
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner in venture and growth capital funds backing technology-focused Canadian companies. It supports emerging and established fund managers to strengthen Canada's innovation ecosystem.